These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

547 related items for PubMed ID: 24007214

  • 1. Analysis of serum exosomal microRNAs and clinicopathologic features of patients with pancreatic adenocarcinoma.
    Que R, Ding G, Chen J, Cao L.
    World J Surg Oncol; 2013 Sep 04; 11():219. PubMed ID: 24007214
    [Abstract] [Full Text] [Related]

  • 2. Exosomal onco-miRs from serum of patients with adenocarcinoma of the esophagus: comparison of miRNA profiles of exosomes and matching tumor.
    Warnecke-Eberz U, Chon SH, Hölscher AH, Drebber U, Bollschweiler E.
    Tumour Biol; 2015 Jun 04; 36(6):4643-53. PubMed ID: 25631748
    [Abstract] [Full Text] [Related]

  • 3. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis.
    Zhou X, Lu Z, Wang T, Huang Z, Zhu W, Miao Y.
    Gene; 2018 Oct 05; 673():181-193. PubMed ID: 29913239
    [Abstract] [Full Text] [Related]

  • 4. Role of exosomal microRNA-125b-5p in conferring the metastatic phenotype among pancreatic cancer cells with different potential of metastasis.
    Wu M, Tan X, Liu P, Yang Y, Huang Y, Liu X, Meng X, Yu B, Wu Y, Jin H.
    Life Sci; 2020 Aug 15; 255():117857. PubMed ID: 32470446
    [Abstract] [Full Text] [Related]

  • 5. A microRNA signature in circulating exosomes is superior to exosomal glypican-1 levels for diagnosing pancreatic cancer.
    Lai X, Wang M, McElyea SD, Sherman S, House M, Korc M.
    Cancer Lett; 2017 May 01; 393():86-93. PubMed ID: 28232049
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer.
    Liu Q, Yu Z, Yuan S, Xie W, Li C, Hu Z, Xiang Y, Wu N, Wu L, Bai L, Li Y.
    Oncotarget; 2017 Feb 21; 8(8):13048-13058. PubMed ID: 28055956
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Usefulness of exosome-encapsulated microRNA-451a as a minimally invasive biomarker for prediction of recurrence and prognosis in pancreatic ductal adenocarcinoma.
    Takahasi K, Iinuma H, Wada K, Minezaki S, Kawamura S, Kainuma M, Ikeda Y, Shibuya M, Miura F, Sano K.
    J Hepatobiliary Pancreat Sci; 2018 Feb 21; 25(2):155-161. PubMed ID: 29130611
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Identification of serum exosomal miR-148a as a novel prognostic biomarker for breast cancer.
    Li D, Wang J, Ma LJ, Yang HB, Jing JF, Jia MM, Zhang XJ, Guo F, Gao JN.
    Eur Rev Med Pharmacol Sci; 2020 Jul 21; 24(13):7303-7309. PubMed ID: 32706068
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.